The Center for Medicare and Medicaid Services (CMS) retroactively added two new CPT codes for respiratory syncytial virus (RSV) vaccine administration to the Medicare Physician Fee Schedule files effective for dates of service on and after October 6, 2023.
National Immunization Awareness Month is an annual observance held in August to highlight the importance of routine vaccination for people of all ages.
The FDA approved the first vaccine (brand name "Arexvy") to prevent infection with Respiratory Syncytial Virus (RSV).
You know how challenging it has been to ensure your patients have been kept up to date on their vaccines. As we all prepare for school to start, and the approach of flu season, take advantage of resources from CDC and others to help get everyone up to date!
National Influenza Vaccination Week is here! If you haven’t received a flu shot yet, there’s still time. People with certain chronic conditions are more likely to develop serious flu complications. Together, we can all #FightFlu. Protect yourself and your loved ones by getting a flu shot.
A new COVID-19 information website, specifically for teens [ncdhhs.gov] launched this week. As COVID-19 rates are rapidly increasing across the state, particularly in young people, this is a useful tool for encouraging vaccination.
The Center for Disease Control (CDC) has a webpage dedicated to bringing you “What’s New & Updated”. Content on the webpage includes significant changes such as new pages and guidance recommendations. This webpage is one of several ways you can stay updated on the most current information around COVID-19. You can also stay updated by signing up for email updates, syndicating available content, and subscribing to the COVID-19 RSS Feed.
A study from April 2021 sponsored by the Robert Wood Johnson Foundation revealed some startling facts about ways we are missing the mark to address vaccine hesitancy among adults aged 18-64.
On July 9, 2021, an addendum to COVID-19 Bulletin #168 was released in SPECIAL BULLETIN COVID-19 #170: Update on Vaccination Counseling Code Reimbursement. Read highlights below.
On Monday May 10, 2021, the FDA amended the December 11, 2020 emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in adolescents 16 or older to include adolescents 12 -15 years of age. The FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria to amend the EUA, and that the known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks, supporting the vaccine’s use in this population.